Dissecting the Roles of High-quality Diets and Ultra Processed Foods on Cardiometabolic Health

NCT ID: NCT06749327

Last Updated: 2025-01-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

330 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-01

Study Completion Date

2029-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Controversy remains around the role of ultra-processed food (UPF) consumption and health outcomes. A key question that remains to be answered is: when diet quality is the same, does food processing itself have any independent health effects? The current application aims to isolate the health effects of food processing from those of diet quality through the conduct of a dietary intervention study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Controversy remains around the role of UPF consumption and health outcomes. A key question that remains to be answered is: When diet quality is the same, does food processing itself have any independent health effects?

The current study aims to isolate the health effects of food processing from those of diet quality through the conduct of a dietary intervention study.

To isolate the health effects of food processing, the investigators propose to use healthy plant-based diets as the "base" diet. The investigators propose to initially discover plasma metabolomic features responsive to improved hPDI adherence and then conduct a dietary intervention trial to evaluate the impact of UPF consumption, in the setting of a high hPDI diet, on cardiometabolic outcomes and metabolic pathways.

The study will consist of a run-in phase where participants with a low adherence to a plant based diet will be randomized into (1) an intervention group that will receive diet counselling to follow a high hPDI diet over a period of 6 weeks and (2) a control group that will consume their usual diet (low hPDI). Both arms will be advised to avoid ultra processed food (UPF) consumption. Assuming 15% attrition, the study will enrol 118 participants for the run-in phase. Individuals with a high adherence to plant based diet will follow their normal diet for the 6 weeks of this run-in phase and then will be randomised into the main 4 month study.

In the main four month study, a randomized controlled parallel group dietary intervention will be conducted in participants with high hPDI in Ireland (North and South) to evaluate the impact of UPF consumption, in the context of a high hPDI diet, on cardiometabolic outcomes such as glycated haemoglobin and total cholesterol, and metabolic pathways. Participants will be randomized into one of 2 groups: high UPF hPDI diet or low UPF hPDI diet. Assuming an attrition rate of 15%, the study will enrol \~212 individuals to achieve a sample size of 180 participants who will complete the trial.

Randomization will be performed using a randomization scheme generated using www.randomization.com with random block sizes by research staff independent of the study. The investigators will stratify randomization according to age and BMI.

Power calculation : Assuming a change in total cholesterol of 9 mg/dL at four months and assuming a SD of change of 20, a total of 78 participants in each group is needed. Allowing for participant dropout of 15%, which is similar to that observed in the investigator's previous interventions, gives an overall sample size of 180.

Based on an SD of difference in change in HbA1c of 0.3%, the same sample size could detect as statistically significant a difference in HBA1c of 0.15% between the two intervention groups at four months.

The total number of participants that will be enrolled will be 330: 118 (run-in phase) and 212 (4 month trial).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiometabolic Risk Factors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High UPF, high hPDI diet

High ultra-processed foods (UPFs) and healthy plant based diet

Group Type EXPERIMENTAL

High UPF, high hPDI diet

Intervention Type BEHAVIORAL

High ultra-processed foods (UPFs) and healthy plant based diet

Low UPF, high hPDI diet

Low ultra-processed foods (UPFs) and high healthy plant-based diet

Group Type ACTIVE_COMPARATOR

Low UPF, high hPDI diet

Intervention Type BEHAVIORAL

Low ultra-processed foods (UPFs) and high healthy plant-based diet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High UPF, high hPDI diet

High ultra-processed foods (UPFs) and healthy plant based diet

Intervention Type BEHAVIORAL

Low UPF, high hPDI diet

Low ultra-processed foods (UPFs) and high healthy plant-based diet

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women aged between 18 and 65 years in general good health with BMI \< 35 kg/m2 who can provide informed consent.

Exclusion Criteria

* Participants will be ineligible to enrol if they have diabetes, CVD, any type of cancer (except for basal cell skin cancer), or a condition (pregnancy, breastfeeding, etc) or dietary restriction(s) that would substantially limit their ability to complete the study.

Individuals will be screened for their adherence to the Plant based diet Index (PDI ).

1. Individuals with low adherence will enter run-in phase only (6 weeks)
2. Individuals with high adherence will enter the main intervention (4 months)
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University College Dublin

OTHER

Sponsor Role collaborator

Harvard School of Public Health (HSPH)

OTHER

Sponsor Role collaborator

Queen's University, Belfast

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jayne Woodside, PhD

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Prof. Lorraine Brennan, PhD

Role: PRINCIPAL_INVESTIGATOR

University College Dublin

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University College Dublin

Dublin, Ireland, Ireland

Site Status

Centre for Public Health, Queen's University Belfast

Belfast, Northern Ireland, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Ireland United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Prof. Jayne Woodside, PhD

Role: CONTACT

+4402890 978942

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Professor Lorraine Brennan, PhD

Role: primary

+353 01 716 6815

Jayne Woodside V Professor, PhD

Role: primary

+44(0)2890 978942

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TBC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CVD Nutrition Education
NCT00005727 COMPLETED NA